A new way to prevent thrombosis?

Abstract

Venous thrombosis is a major problem in paroxysmal nocturnal hemoglobinuria (PNH). The studies of Hillmen and colleagues in this issue of Blood show that an antibody to complement C5, eculizumab (Soliris), markedly inhibits thrombosis in affected patients.